These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 3805869)

  • 1. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
    Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
    Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
    J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
    Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
    J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
    Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
    J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
    Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
    Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
    Gadek JE; Hunninghake GW; Zimmerman RL; Crystal RG
    Am Rev Respir Dis; 1980 Apr; 121(4):723-33. PubMed ID: 6992662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA; Gallin JI; Reynolds HY
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chemotactic factor inactivation in neutrophil chemotaxis.
    Tannous R; Cavender-Zylich N; Ginsberg BH
    J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human alveolar macrophages release a factor that inhibits phagocyte function.
    Sibille Y; Merrill WW; Naegel GP; Care SB; Cooper JA; Reynolds HY
    Am J Respir Cell Mol Biol; 1989 Nov; 1(5):407-16. PubMed ID: 2561589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of chemotactic factor inactivator in alcoholic liver disease.
    Robbins RA; Zetterman RK; Kendall TJ; Gossman GL; Monsour HP; Rennard SI
    Hepatology; 1987; 7(5):872-7. PubMed ID: 3653852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
    Martin TR; Raugi G; Merritt TL; Henderson WR
    J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fragments, alveolar macrophages, and alveolitis.
    Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
    Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine spermadhesin PSP-I/PSP-II stimulates macrophages to release a neutrophil chemotactic substance: modulation by mast cells.
    Assreuy AM; Alencar NM; Cavada BS; Rocha-Filho DR; Feitosa RF; Cunha FQ; Calvete JJ; Ribeiro RA
    Biol Reprod; 2003 May; 68(5):1836-41. PubMed ID: 12606406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    Senior RM; Griffin GL; Perez HD; Webster RO
    J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.